Trending Medical and health breaking news Rivaroxaban Safely Cuts VTE Risk After COVID-19 Hospitalization

Trending Medical and well being breaking information Rivaroxaban Safely Cuts VTE Danger After COVID-19 Hospitalization

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Extended anticoagulation with low-dose rivaroxaban (Xarelto, Bayer/Janssen) after hospitalization for COVID-19 may reduce the risk of venous thromboembolism (VTE) without worsening the risk of bleeding in patients who had been considered high-risk for VTE, a multicenter randomized trial suggests. The primary…